Post-earnings recap
Reported
Thu, Apr 30, 2026
EPS actual
$0.94
EPS est.
$0.73
EPS surprise
+28.77%
1-day move
+5.15%
Merit Medical Systems reported stronger-than-expected earnings per share, which likely contributed to the stock's positive reaction, rising 5.15%. However, revenue figures were not disclosed, leaving some uncertainty about overall performance. Investors may be encouraged by the EPS beat, but the lack of additional financial details and guidance could lead to cautious sentiment moving forward.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.94 | $0.83 | +28.77% |
| Revenue | N/A | $378M | N/A |
No transcript is on record, so the analysis is based on numerical results only.
Merit Medical Systems, Inc. (MMSI) operates in the health care sector, focusing on providing medical supplies and devices. As a key player in health care supplies, its performance can be influenced by trends in health care spending and advancements in medical technology.
Last quarter
In Q4-2025, Merit Medical reported an EPS of $1.04, significantly beating expectations. The stock reacted positively, gaining 1.00% the following day.
Management promises and guidance
EPS beat streak
8Q
EPS beat rate
100%
Avg EPS surprise
+21.38%
Avg 1-day reaction
+1.24%
Analysts expect Merit Medical to report solid earnings this quarter, with a consensus EPS of $0.83. Given the company's strong track record of beating estimates, there is optimism around its performance.
Bull case
If Merit Medical exceeds the EPS estimate, it could signal strong demand for its products and further growth potential, leading to a positive stock reaction.
Bear case
Conversely, if the company fails to meet expectations, it may raise concerns about its market position and future growth, potentially resulting in a negative stock response.
Key metrics to watch
Earnings Per Share (EPS)
$0.83EPS is a critical measure of profitability and indicates how much profit a company makes for each share of its stock.
Revenue
$378MRevenue growth is essential for assessing the company's ability to expand its operations and market presence.
The print will turn on these.
Q1
Will EPS exceed the consensus estimate of $0.83?
A higher EPS would reinforce the company's growth narrative and could lead to a positive market reaction.
Q2
What guidance can management provide regarding future revenue growth?
Clear guidance on revenue expectations will be crucial for investor confidence and could impact stock performance.
—
Est. EPS
$1.94
Est. Rev
$3.0B
Impl. Move
±9.9%
Why consensus could be wrong
The consensus may underestimate the potential for revenue growth driven by new product launches and market expansion efforts.
Supporting evidence
Merit Medical has consistently beaten EPS estimates, indicating stronger-than-expected demand.
The options market is pricing a larger move than historical averages, suggesting heightened expectations.
Management's previous commitments to operational improvements could lead to better-than-expected results.
Key risk
If revenue growth exceeds $380M, it could challenge the current consensus outlook.
Pre-commit to what would confirm each case.
This quarter's performance will be closely watched as it follows a series of strong earnings surprises, setting high expectations.
Bull confirmed if
An EPS of $0.85 or higher would confirm strong operational performance and growth.
Bear confirmed if
An EPS below $0.81 could indicate underlying issues and lead to negative sentiment.
What the market is pricing for the move.
Implied Move
±9.84%
Historical Avg
±1.9%
The options market is pricing in a significant move, suggesting that traders expect volatility around the earnings announcement.
Options are pricing ±9.8% while MMSI has averaged ±1.9% over the last 8 prints — setup is pricing rich.
ATM IV
0.6%
30d HV
25.3%
Cross-company pattern from 30 similar setups.
Prior-quarter beat + options rich in Health Care
Fade rate: 7 of 23 (30%)
This setup has occurred 30 times across Health Care in the last 2 years. 16 of 23 (70%) held or extended their move within 5 days — this setup typically holds direction. The average absolute 1-day move is 4.2%, with a raw directional average of +0.6% (modestly positive historical bias).
Smart-money positioning from the most recent 13F filings.
Institutional
107.69%
of float
Insider
2.45%
of float
Holders
548
institutions
Top Holders· as of Jun 2026
Blackrock Inc.
9,464,542 sh · $805.3M
15.85%
7.1%
Likely market behavior by outcome. Not investment advice.
Beat & raise
If Merit Medical beats expectations, history suggests the stock could rise around 1.16% on average, confirming positive momentum.
In line / cautious
If results are in line with expectations, the stock may experience muted movement as investors await further insights from management.
Miss
If the company misses estimates, the stock could decline, with historical patterns suggesting an average drop of around 0.13%.
The lines on the call that would change the story.
Vanguard Portfolio Management LLC
3,473,833 sh · $295.6M
5.82%
-1.4%
Vanguard Capital Management LLC
2,590,454 sh · $220.4M
4.34%
-2.5%
State Street Corporation
2,474,512 sh · $210.6M
4.14%
4.8%
Conestoga Capital Advisors, LLC
1,979,790 sh · $168.5M
3.32%
-8.7%
13F filings updated quarterly. Position deltas show change in shares vs. the prior quarter.